Search Within

William Douglas Tap

Formats
  1. Journal Article (194)
  2. Meeting Abstract (159)
  3. Review (12)
  4. Book Section (4)
  5. Editorial (4)
  6. Guidelines (3)
  7. Miscellaneous (2)
  8. Research Letter (1)
Groups
  1. Department of Medicine (379)
  2. Sarcoma Service (379)
  3. Solid Tumor Oncology Division (379)
  4. GSK Faculty (159)
  5. Tow Center for Developmental Oncology (TCDO) (149)
  6. Department of Pathology and Laboratory Medicine (133)

More Groups

People
  1. Sandra D'Angelo (106)
  2. Cristina Antonescu (97)
  3. Mark Dickson (92)
  4. Samuel Singer (80)
  5. Mrinal Gounder (79)
  6. Mary Keohan (77)

More People

Years
  1. 2025 (21)
  2. 2024 (50)
  3. 2023 (34)
  4. 2022 (43)
  5. 2021 (25)
  6. 2020 (34)

More Years

Publications
  1. Journal of Clinical Oncology (102)
  2. Annals of Oncology (30)
  3. Clinical Cancer Research (27)
  4. Cancer Research (14)
  5. Modern Pathology (11)
  6. Lancet Oncology (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (109)
  2. American Association for Cancer Research (48)
  3. Oxford University Press (39)
  4. Elsevier Science, Inc. (22)
  5. Elsevier Inc. (21)
  6. Nature Publishing Group (19)

More Publishers

Results (379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Initial results from the phase (ph) 1 portion of a ph 1/2 study of THE-630 in patients (pts) with advanced gastrointestinal stromal tumor (GIST)
    Meeting Abstract

    George, S.; Tap, W. D.; von Mehren, M.; Gordon, M. S.; Trent, J. C.; Attia, S.; Zhang, S.; Narasimhan, N.; Rivera, V. M.; Kerstein, D.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Real-world utilization pattern of pexidartinib in patients with tenosynovial giant cell tumor (TGCT)
    Meeting Abstract

    Lin, F.; Tse, J.; Shaikh, N. F.; Wang, E. J.; Near, A.; Kwong, J.; Tap, W. D.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts
    Meeting Abstract

    Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase I study of the mutant IDH1 inhibitor ivosidenib: Long-term safety and clinical activity in patients with conventional chondrosarcoma
    Meeting Abstract

    Tap, William D.; Cote, Gregory Michael; Burris, Howard A.; Gore, Lia; Beeram, Muralidhar; Conley, Anthony Paul; Gianolio, Diego A.; Qu, Zhe; Gliser, Camelia; Pandya, Shuchi Sumant; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Safety, pharmacokinetics (PK), and clinical activity of bezuclastinib + sunitinib in previously-treated gastrointestinal stromal tumor (GIST): Results from part 1 of the phase 3 Peak study
    Meeting Abstract

    Tap, W. D.; Wagner, A. J.; Bauer, S.; Heinrich, M. C.; Jones, R. L.; Serrano, C.; von Mehren, M.; Somaiah, N.; Andor, T.; Zou, L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A pilot study of lenvatinib plus pembrolizumab in patients with advanced sarcoma
    Meeting Abstract

    Movva, S.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, Ciara M.; Keohan, M. L.; Meyers, P. A.; Cohen, S. M.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Interim results of a phase II trial of first line retifanlimab (R) plus gemcitabine and docetaxel (GD) in patients (pts) with advanced soft tissue sarcoma (STS)
    Meeting Abstract

    Rosenbaum, E.; Qin, L. X.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Chi, P.; Movva, S.; Kelly, C. M.; Avutu, V.; Chan, J. E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Redefining early-onset cancer and risk of hereditary cancer predisposition
    Meeting Abstract

    Stadler, Z. K.; Maio, A.; Khurram, A.; Kemel, Y.; Padunan, A.; Borio, M.; Sheehan, M.; Murciano-Goroff, Y. R.; Walsh, M. F.; Will, M.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Distinct IDH1/2-associated methylation profile and enrichment of TP53 and TERT mutations distinguish dedifferentiated chondrosarcoma from conventional chondrosarcoma
    Journal Article

    Dermawan, J. K. T.; Nafa, K.; Mohanty, A.; Xu, Y.; Rijo, I.; Casanova, J.; Villafania, L.; Benhamida, J.; Kelly, C. M.; Tap, W. D.; more...
    Cancer Research Communications (2023)

    Fulltext@MSK | Save
  • Stereotactic body radiation therapy for sarcoma pulmonary metastases
    Journal Article

    Lebow, E. S.; Lobaugh, S. M.; Zhang, Z.; Dickson, M. A.; Rosenbaum, E.; D'Angelo, S. P.; Nacev, B. A.; Shepherd, A. F.; Shaverdian, N.; Wolden, S.; more...
    Radiotherapy and Oncology (2023)

    Fulltext@MSK | Save